-
Je něco špatně v tomto záznamu ?
Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid)
S. Esposito, P. Bonanni, S. Maggi, L. Tan, F. Ansaldi, PL. Lopalco, R. Dagan, JP. Michel, P. van Damme, J. Gaillat, R. Prymula, T. Vesikari, C. Mussini, U. Frank, A. Osterhaus, LP. Celentano, M. Rossi, V. Guercio, G. Gavazzi,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, směrnice pro lékařskou praxi, přehledy, práce podpořená grantem
NLK
Free Medical Journals
od 2012 do Před 1 rokem
PubMed Central
od 2012 do Před 1 rokem
Europe PubMed Central
od 2012 do Před 1 rokem
- MeSH
- dospělí MeSH
- infekční nemoci epidemiologie MeSH
- lidé MeSH
- očkovací schéma * MeSH
- přenos infekční nemoci prevence a kontrola MeSH
- vakcíny aplikace a dávkování MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- směrnice pro lékařskou praxi MeSH
- Geografické názvy
- Evropa MeSH
Rapid population aging has become a major challenge in the industrialized world and progressive aging is a key reason for making improvement in vaccination a cornerstone of public health strategy. An increase in age-related disorders and conditions is likely to be seen in the near future, and these are risk factors for the occurrence of a number of vaccine-preventable diseases. An improvement in infectious diseases prevention specifically aimed at adults and the elderly can therefore also decrease the burden of these chronic conditions by reducing morbidity, disability, hospital admissions, health costs, mortality rates and, perhaps most importantly, by improving the quality of life. Among adults, it is necessary to identify groups at increased risk of vaccine-preventable diseases and highlight the epidemiological impact and benefits of vaccinations using an evidence-based approach. This document provides clinical practice guidance on immunization for adults in order to provide recommendations for decision makers and healthcare workers in Europe. Although immunization is considered one of the most impactful and cost-effective public health measures that can be undertaken, vaccination coverage rates among adults are largely lower than the stated goal of ≥ 95% among adults, and stronger efforts are needed to increase coverage in this population. Active surveillance of adult vaccine-preventable diseases, determining the effectiveness of the vaccines approved for marketing in the last 5 y, the efficacy and safety of vaccines in immunocompromised patients, as well as in pregnant women, represent the priorities for future research.
b Department of Health Sciences University of Florence Florence Italy
c CNR Institute of Neuroscience Aging Branch Center for Research Padua Italy
f Unit of Public Health University of Bari Bari Italy
h Geriatric Department Geneva University Geneva Switzerland
i Vaccine and Infectious Disease Institute Antwerp University Wilrijk Belgium
Immunization Action Coalition St Paul MN USA
j Department of Infectious Disease Annecy France
l Vaccine Research Center Tampere University Hospital Tampere Finland
m Clinic of Infectious Diseases University of Modena and Reggio Emilia Modena Italy
o University of Veterinary Medicine Hannover Hannover Germany
p European Centers for Disease Control and Prevention Stockholm Sweden
q Department of Clinical Sciences and Community Health Università degli Studi di Milano Milan Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017277
- 003
- CZ-PrNML
- 005
- 20180515103128.0
- 007
- ta
- 008
- 180515s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/21645515.2016.1150396 $2 doi
- 035 __
- $a (PubMed)27135390
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Esposito, Susanna $u a Pediatric Highly Intensive Care Unit, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico , Milan , Italy.
- 245 10
- $a Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid) / $c S. Esposito, P. Bonanni, S. Maggi, L. Tan, F. Ansaldi, PL. Lopalco, R. Dagan, JP. Michel, P. van Damme, J. Gaillat, R. Prymula, T. Vesikari, C. Mussini, U. Frank, A. Osterhaus, LP. Celentano, M. Rossi, V. Guercio, G. Gavazzi,
- 520 9_
- $a Rapid population aging has become a major challenge in the industrialized world and progressive aging is a key reason for making improvement in vaccination a cornerstone of public health strategy. An increase in age-related disorders and conditions is likely to be seen in the near future, and these are risk factors for the occurrence of a number of vaccine-preventable diseases. An improvement in infectious diseases prevention specifically aimed at adults and the elderly can therefore also decrease the burden of these chronic conditions by reducing morbidity, disability, hospital admissions, health costs, mortality rates and, perhaps most importantly, by improving the quality of life. Among adults, it is necessary to identify groups at increased risk of vaccine-preventable diseases and highlight the epidemiological impact and benefits of vaccinations using an evidence-based approach. This document provides clinical practice guidance on immunization for adults in order to provide recommendations for decision makers and healthcare workers in Europe. Although immunization is considered one of the most impactful and cost-effective public health measures that can be undertaken, vaccination coverage rates among adults are largely lower than the stated goal of ≥ 95% among adults, and stronger efforts are needed to increase coverage in this population. Active surveillance of adult vaccine-preventable diseases, determining the effectiveness of the vaccines approved for marketing in the last 5 y, the efficacy and safety of vaccines in immunocompromised patients, as well as in pregnant women, represent the priorities for future research.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a infekční nemoci $x epidemiologie $7 D003141
- 650 _2
- $a přenos infekční nemoci $x prevence a kontrola $7 D018562
- 650 _2
- $a Evropa $7 D005060
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a očkovací schéma $7 D007115
- 650 _2
- $a vakcíny $x aplikace a dávkování $7 D014612
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bonanni, Paolo $u b Department of Health Sciences , University of Florence , Florence , Italy.
- 700 1_
- $a Maggi, Stefania $u c CNR - Institute of Neuroscience, Aging Branch Center for Research , Padua , Italy.
- 700 1_
- $a Tan, Litjan $u d Immunization Action Coalition , St Paul , MN , USA.
- 700 1_
- $a Ansaldi, Filippo $u e Department of Health Sciences , University of Genoa, IRCCS San Martino-IST University Teaching Hospital , Genoa , Italy.
- 700 1_
- $a Lopalco, Pier Luigi $u f Unit of Public Health, University of Bari , Bari , Italy.
- 700 1_
- $a Dagan, Ron $u g Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University , Beer-Sheva , Israel.
- 700 1_
- $a Michel, Jean-Pierre $u h Geriatric Department , Geneva University , Geneva , Switzerland.
- 700 1_
- $a van Damme, Pierre $u i Vaccine & Infectious Disease Institute, Antwerp University , Wilrijk , Belgium.
- 700 1_
- $a Gaillat, Jacques $u j Department of Infectious Disease , Annecy , France.
- 700 1_
- $a Prymula, Roman $u k Department of Social Medicine , Faculty of Medicine, Charles University , Sokolska, Hradec Kralove , Czech Republic.
- 700 1_
- $a Vesikari, Timo $u l Vaccine Research Center, Tampere University Hospital , Tampere , Finland.
- 700 1_
- $a Mussini, Cristina $u m Clinic of Infectious Diseases, University of Modena and Reggio Emilia , Modena , Italy.
- 700 1_
- $a Frank, Uwe $u n Division of Infection Control and Hospital Epidemiology, Department of Infectious Diseases, Heidelberg University , Heidelberg , Germany.
- 700 1_
- $a Osterhaus, Albert $u o University of Veterinary Medicine Hannover , Hannover , Germany.
- 700 1_
- $a Celentano, Lucia Pastore $u p European Centers for Disease Control and Prevention , Stockholm , Sweden.
- 700 1_
- $a Rossi, Marta $u q Department of Clinical Sciences and Community Health , Università degli Studi di Milano , Milan , Italy.
- 700 1_
- $a Guercio, Valentina $u q Department of Clinical Sciences and Community Health , Università degli Studi di Milano , Milan , Italy.
- 700 1_
- $a Gavazzi, Gaetan $u r University Clinic of Geriatric Medicine, University Hospital of Grenoble, and GREPI University of Grenoble-Alpes , Grenoble , France.
- 773 0_
- $w MED00181409 $t Human vaccines & immunotherapeutics $x 2164-554X $g Roč. 12, č. 7 (2016), s. 1777-94
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27135390 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180515103302 $b ABA008
- 999 __
- $a ok $b bmc $g 1300901 $s 1014117
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 12 $c 7 $d 1777-94 $e 20160502 $i 2164-554X $m Human vaccines & immunotherapeutics $n Hum Vaccin Immunother $x MED00181409
- LZP __
- $a Pubmed-20180515
